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persistent threat of embolization and potential frustration of the
prosthetic valve with a beating heart after clamp removal.
De-airing of the heart after AVR using a standard, rigorous tech-
nique with aortic root and left ventricular vents creates transient
conditions during which negative pressure and low, turbulent flows
exist. These conditions may favor the aggregation of glue particles
once inside the aorta in a similar fashion to conditions favoring
thrombus formation as stated in Virchow’s triad.5 We propose that
even rapidly polymerizing cyanoacrylate glues should be used with
caution at aortic suture lines and, in particular, that the timing of
application with respect to de-airing using aortic root vents is critical.
References
1. Karimi M, Kerber RE, Everett JE. Mechanical aortic valve malfunction:
an intraoperative BioGlue complication. J Thorac Cardiovasc Surg.
2005;129:1442-3.
2. Guerrero MA, Cox M, Lumsden AB, Reardon M, Howell J. Embolus of
surgical adhesive to the extremities causing acute ischemia: report of
two cases. J Vasc Surg. 2004;40:571-3.
3. Robicsek F, Rielly JP, Marroum MC. The use of cyanoacrylate adhesive
(Krazy Glue) in cardiac surgery. J Card Surg. 1994;9:353-6.
4. Braunwald NS. A clinical evaluation of methyl-2-cyanoacrylate mono-
mer as a hemostatic agent on the aorta. Ann Surg. 1966;164:967-72.
5. Lowe GD. Virchow’s triad revisited: abnormal flow. Pathophysiol
Haemost Thromb. 2003;33:455-7.
Mechanical valve obstruction caused by an occlusion device
Ofer Merin, MD, Dani Bitran, MD, Daniel Fink, MD, Esther Asher, MA, and Shuli Silberman, MD, Jerusalem, Israel
Mechanical occlusion devices are used mainly for theclosure of septal defects or patent ductus. Therehave been some reports of their use for the closureof paravalvular leaks after valve replacement.
The potential for leaflet obstruction of a mechanical mitral
prosthesis has so far been unrecognized. This is the first report
of this potential complication.
Clinical Summary
A 74-year-old woman underwent coronary bypass and aortic valve
replacement with a mechanical device 13 years ago. Two years
before the current admission, she underwent a second operation to
replace her mitral valve because of heart failure secondary to
severe mitral incompetence. Her valve was replaced with a St Jude
25-mm valve (St Jude Medical, St Paul, Minn). Shortly thereafter,
shortness of breath developed in the patient, and a severe paraval-
vular leak was seen on the mitral prosthesis. She then underwent
attempted closure of the paravalvular leak with percutaneous in-
sertion of an Amplatzer occlusion device (AGA Medical Corpo-
ration, Golden Valley, Minn). Her condition continued to deteri-
orate, hemolytic anemia developed, and severe mitral regurgitation
persisted (seen on echocardiography as an eccentric jet). Fluoros-
copy (Figure 1) showed that 1 of the valve leaflets, adjacent to the
device, was immobile. She was then referred to our department
for repeat mitral valve replacement. The occlusion device was
found to impinge on the posterior leaflet, restricting it in a
closed position (Figure 2). The mitral valve was replaced with
a bioprosthesis. The operation and immediate postoperative
course were uneventful; however, on the day after surgery
massive bleeding developed from the mediastinal drains. Emer-
gency exploration was undertaken in the intensive care unit,
which revealed bleeding from the area of the inferoposterior left
ventricular wall, suggestive of atrioventricular rupture. The
patient could not be resuscitated, and she died. Reexamination
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Figure 2. Fragments of glue extricated from aortic root (ruler
scale in centimeters).
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of the angiogram revealed a relatively large distance between
the original mitral prosthesis and the calcified mitral annulus.
This indicates that atrioventricular disruption may have been
present before surgery but was contained because of adhesions;
however, we could not be certain that the device directly contrib-
uted to the catastrophic event.
Discussion
Percutaneous insertion of occluding devices is used mainly for
closure of intracardiac defects. Transcatheter closure of paraval-
vular leaks was first reported by Hourihan and colleagues1 in 1992.
There have been other reports of the use of occlusion devices in the
mitral position2 and aortic position.3
Pate and colleagues4 summarized the techniques and con-
siderations of percutaneous device use for closure of prosthetic
valve leaks. In their article they mention a number of potential
device-related complications, such as valve dehiscence, device
embolization, infection, wire trauma, valve leaflet damage, im-
pingement of valve leaflet motion, and hemolysis. Hussain and
colleagues5 reported a case of attempted repair of paravalvular
prosthetic mitral leak with an Amplatzer device (AGA Medical
Corporation). The patient continued to demonstrate congestive
heart failure and hemolysis secondary to persistent paravalvular
leak and required surgery to remove the old prosthesis and the
device.
Our patient presented with severe congestive heart failure
and hemolysis. The intention of avoiding surgery was not
realized. Furthermore, she underwent surgery in a compromised
clinical state. Current devices are not geometrically adapted to
the anatomy of paravalvular leaks. A device may successfully
repair a small leak but also propagate valve dehiscence. We
believe that paravalvular leaks are best treated with reoperation.
At this time, the use of percutaneous occlusion devices for
closure of paravalvular leaks should be limited to those patients
who are not surgical candidates. To our knowledge, our case is
the first report of a device impinging on the valve leaflet.
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Figure 2. Explanted prosthetic valve with the occlusion device.
The valve leaflet adjacent to the device was immobilized in the
closed position.Figure 1. Mechanical mitral prosthesis with 1 leaflet visible in
the open position. The other leaflet immobilized by the occlusion
device cannot be visualized.
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